Screener
Medtronic MDT Other Operating Segments, Including Diabetes — Depreciation expense
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Medtronic in its filing.
Tagged under the XBRL concept us-gaap:Depreciation.
The source filing: Medtronic’s 10-K, filed June 18, 2026.
- Filed
- Jun 18, 2026, 4:27 PM EDT
- Fiscal year
- FY2026
- Accession
- 0001628280-26-044354
| (in millions) | Total Assets / April 24, 2026 | Total Assets / April 25, 2025 | Depreciation Expense / 2026 | Depreciation Expense / 2025 | Depreciation Expense / 2024 |
|---|---|---|---|---|---|
| Cardiovascular | $17,553 | $16,548 | $253 | $225 | $199 |
| Neuroscience | 18,514 | 18,476 | 320 | 282 | 252 |
| Medical Surgical | 32,535 | 33,317 | 225 | 205 | 194 |
| Total reportable segments | 68,602 | 68,340 | 798 | 711 | 645 |
| Other operating segments (1) | 4,827 | 4,433 | 127 | 113 | 94 |
| Corporate | 19,598 | 18,906 | 261 | 229 | 215 |
| Total | $93,028 | $91,680 | $1,186 | $1,054 | $954 |
Item 8. Financial Statements and Supplementary Data
FAQ
- What is Medtronic's other operating segments, including diabetes — depreciation expense?
- Medtronic (MDT) reported other operating segments, including diabetes — depreciation expense of $31.75M in Q1 2026.
- How has Medtronic's other operating segments, including diabetes — depreciation expense changed year-over-year?
- Medtronic's other operating segments, including diabetes — depreciation expense increased by 12.4% year-over-year, from $28.25M to $31.75M.
- What is the long-term trend for Medtronic's other operating segments, including diabetes — depreciation expense?
- Over 2 years (2024 to 2026), Medtronic's other operating segments, including diabetes — depreciation expense has grown at a 16.2% compound annual growth rate (CAGR), from $94M to $127M.
- What does other operating segments, including diabetes — depreciation expense mean?
- This metric reflects the systematic allocation of the cost of tangible assets used within the secondary operating segments over their useful lives. It provides insight into the capital expenditure intensity and the aging profile of the manufacturing and research infrastructure supporting these business units. High depreciation relative to segment revenue often indicates a capital-intensive production model.
Ask your AI about Medtronic's other operating segments, including diabetes — depreciation expense.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude